Hims & Hers Health, Inc. (HIMS) call put ratio 1.6 calls to 1 put into quarter results and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Hims and Hers (HIMS) PT Raised to $28 at BofA Securities
May 6, 2025 6:59 AM EDTBofA Securities analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $28.00 (from $26.00) while maintaining a Underperform rating.
The analyst comments "Following this quarters earnings, we see a wider range of outcomes for full year revenue (link to our first take here). In the first scenario, if HIMS were to grow its... More
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS)
May 6, 2025 4:58 AM EDTBofA Securities analyst Michael Cherny reiterated an Underperform rating and $26.00 price target on Hims and Hers (NYSE: HIMS).
The analyst comments "HIMS reported a strong quarter, with revenue of $586MM well ahead of the guidance/consensus and slightly ahead of BofAs estimate of $583.1MM. Second quarter... More
